5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.14▲ | 1.13▲ | 1.14▲ | 1.14▼ | 0.94▲ |
MA10 | 1.14▲ | 1.13▲ | 1.15▼ | 1.03▲ | 0.82▲ |
MA20 | 1.13▲ | 1.16▼ | 1.16▼ | 0.94▲ | 0.75▲ |
MA50 | 1.13▲ | 1.16▼ | 1.10▲ | 0.79▲ | 0.96▲ |
MA100 | 1.16▼ | 1.09▲ | 0.99▲ | 0.73▲ | 0.90▲ |
MA200 | 1.16▼ | 0.99▲ | 0.87▲ | 0.84▲ | 1.94▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | -0.003▼ | -0.011▼ | 0.025▲ | 0.062▲ |
RSI | 52.838▲ | 47.181▼ | 50.611▲ | 70.453▲ | 63.077▲ |
STOCH | 71.296 | 49.032 | 24.823 | 81.532▲ | 76.840 |
WILL %R | -22.222▲ | -63.158 | -69.565 | -25.000 | -15.172▲ |
CCI | 30.730 | 15.013 | -50.622 | 80.251 | 210.019▲ |
▼ GAP | $OCGN Open Gap Down %2 | Set Alert |
Monday, June 16, 2025 05:17 AM
The OCU410ST Phase 2/3 pivotal confirmatory trial represents a major advancement as Ocugen's second late-stage clinical program. Ocugen plans to submit a BLA for OCU410ST in 2027 in alignment with its ...
|
Thursday, June 12, 2025 05:00 PM
MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced ...
|
Thursday, June 12, 2025 02:00 PM
Ocugen, Inc. (NASDAQ: OCGN) announced its participation in the 2025 BIO International Convention, held from June 16-19 at the Boston Convention & Exhibition Center. The biopharmaceutical company ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 1.17 | 1.17 | 1.10 | 1.13 | 4,866,507 |
12/06/25 | 1.19 | 1.23 | 1.13 | 1.20 | 4,713,035 |
11/06/25 | 1.18 | 1.24 | 1.14 | 1.16 | 5,831,230 |
10/06/25 | 1.10 | 1.14 | 1.07 | 1.135 | 3,646,255 |
09/06/25 | 1.13 | 1.24 | 1.05 | 1.09 | 10,148,858 |
06/06/25 | 0.9899 | 1.06 | 0.975 | 1.06 | 8,002,322 |
05/06/25 | 0.90 | 1.01 | 0.90 | 0.9529 | 11,083,753 |
04/06/25 | 0.8625 | 0.8959 | 0.8556 | 0.8872 | 3,456,019 |
03/06/25 | 0.83 | 0.859 | 0.81 | 0.8516 | 3,352,362 |
02/06/25 | 0.8306 | 0.87 | 0.80 | 0.8372 | 3,473,674 |
|
|
||||
|
|
||||
|
|